Display options
Cite
Reginster JY, Bruyère O, Conaghan PG, et al. Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms. Drugs Aging. 2019;36:3-6doi: 10.1007/s40266-019-00659-8.
Reginster, J. Y., Bruyère, O., Conaghan, P. G., McAlindon, T., & Cooper, C. (2019). Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms. Drugs & aging, 363-6. https://doi.org/10.1007/s40266-019-00659-8
Reginster, Jean-Yves, et al. "Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms." Drugs & aging vol. 36 (2019): 3-6. doi: https://doi.org/10.1007/s40266-019-00659-8
Reginster JY, Bruyère O, Conaghan PG, McAlindon T, Cooper C. Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms. Drugs Aging. 2019 Apr;36:3-6. doi: 10.1007/s40266-019-00659-8. PMID: 31073919; PMCID: PMC6509090.
Copy Download .nbib Format: NLM
Share it on

Drugs Aging. 2019 Apr;36:3-6. doi: 10.1007/s40266-019-00659-8.

Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms.

Drugs & aging

Jean-Yves Reginster, Olivier Bruyère, Philip G Conaghan, Tim McAlindon, Cyrus Cooper

Affiliations

  1. Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium. [email protected].
  2. WHO Collaborating Centre for Public Heath Aspects of Musculoskeletal Health and Aging, Liège, Belgium. [email protected].
  3. Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia. [email protected].
  4. Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
  5. WHO Collaborating Centre for Public Heath Aspects of Musculoskeletal Health and Aging, Liège, Belgium.
  6. Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  7. Division of Rheumatology, Tufts Medical Center, Boston, MA, USA.
  8. MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, Southampton, UK.
  9. Musculoskeletal Biomedical Research Unit, National Institute for Health Research (NIHR), University of Oxford, Oxford, UK.

PMID: 31073919 PMCID: PMC6509090 DOI: 10.1007/s40266-019-00659-8

[No abstract available.]

References

  1. Ann Rheum Dis. 2003 Dec;62(12):1145-55 - PubMed
  2. Ann Intern Med. 2004 Nov 16;141(10):781-8 - PubMed
  3. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002946 - PubMed
  4. Osteoarthritis Cartilage. 2010 Mar;18(3):289-96 - PubMed
  5. Lancet. 2011 Jun 18;377(9783):2115-26 - PubMed
  6. Arthritis Care Res (Hoboken). 2012 Apr;64(4):465-74 - PubMed
  7. Osteoarthritis Cartilage. 2014 Mar;22(3):363-88 - PubMed
  8. Semin Arthritis Rheum. 2014 Dec;44(3):253-63 - PubMed
  9. Cochrane Database Syst Rev. 2015 Jan 28;1:CD005614 - PubMed
  10. Osteoarthritis Cartilage. 2015 May;23(5):747-60 - PubMed
  11. Drugs Aging. 2016 Feb;33(2):75-85 - PubMed
  12. BMJ. 2016 Oct 3;355:i5078 - PubMed
  13. Aging Clin Exp Res. 2018 Feb;30(2):111-117 - PubMed
  14. Aging Clin Exp Res. 2018 Apr;30(4):411-412 - PubMed

Publication Types

Grant support